与酒精和阿片类药物使用相关的失眠治疗:叙述性综述
Morohunfolu Akinnusi1,2, Amber Martinson3, Ali A El-Solh1,2,4
1The Veterans Affairs Western New York Healthcare System, 3495 Bailey Avenue, Buffalo, NY 14215 USA.
Sleep and biological rhythms
|September 20, 2024
概括
药物使用障碍 (SUDs) 显著扰乱睡眠,在解毒过程中经常恶化. 将并发性失眠作为一种独特的疾病来治疗,对于恢复和预防成复发至关重要.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
背景情况:
- 药物使用障碍 (SUD) 经常伴有严重的睡眠障碍,影响心理和身体健康.
- 失眠,睡眠碎片化和昼夜节律障碍在SUD患者中很常见.
研究的目的:
- 在SUD中审查睡眠障碍的神经电路.
- 探索酒精使用障碍 (AUD) 和阿片类药物使用障碍 (OUD) 中睡眠问题的治疗选择.
主要方法:
- 在PubMed,Embase,CINAHL Plus,Cochrane 和 Scopus (2000-2023) 的综合文献搜索.
- 专注于最近的出版物和与睡眠和AUD/OUD相关的随机对照试验.
主要成果:
- 失眠和成之间存在双向关系,影响临床结果.
- 失眠经常在解毒期间重新出现,如果不治疗,可能会引发复发.
- 认知行为疗法 (CBT) 和药物疗法在SUD患者的失眠中表现出不同的疗效.
结论:
- 清醒本身并不能保证恢复正常的睡眠模式.
- 在SUD患者的并发性失眠需要独立治疗.
- 需要进一步的研究和临床试验,以指导SUD人群的失眠管理.
相关概念视频
Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
CNS Depressants: Barbiturates and Benzodiazepines
231
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
231
Sedatives and Hypnotics Drugs: Miscellaneous Agents
157
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
157
CNS Depressants: Alcohol and Nicotine
180
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
180
Depressants
104
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
104
Insomnia
79
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
79


